![](/img/cover-not-exists.png)
Intermittent chemotherapy in patients with metastatic androgen-independent prostate cancer : Results from ASCENT, a double-blinded, randomized comparison of high-dose calcitriol plus docetaxel with placebo plus docetaxel
Tomasz M. Beer, Christopher W. Ryan, Peter M. Venner, Daniel P. Petrylak, Gurkamal S. Chatta, J. Dean Ruether, Kim N. Chi, James Young, W. David HennerVolume:
112
Year:
2008
Language:
english
Pages:
5
DOI:
10.1002/cncr.23163
File:
PDF, 109 KB
english, 2008